PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
Authors:
Open Access
- 6 January 2023
- journal article
- research article
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 55 (1) , 132-142
Abstract
Hepatocellular carcinoma (HCC) pathogenesis is associated with alterations in splicing machinery components (spliceosome and splicing factors) and aberrant expression of oncogenic splice variants. We aimed to analyze the expression and potential role of the spliceosome component PRPF8 (pre-mRNA processing factor 8) in HCC. PRPF8 expression (mRNA/protein) was analyzed in a retrospective cohort of HCC patients (n = 172 HCC and nontumor tissues) and validated in two in silico cohorts (TCGA and CPTAC). PRPF8 expression was silenced in liver cancer cell lines and in xenograft tumors to understand the functional and mechanistic consequences. In silico RNAseq and CLIPseq data were also analyzed. Our results indicate that PRPF8 is overexpressed in HCC and associated with increased tumor aggressiveness (patient survival, etc.), expression of HCC-related splice variants, and modulation of critical genes implicated in cancer-related pathways. PRPF8 silencing ameliorated aggressiveness in vitro and decreased tumor growth in vivo. Analysis of in silico CLIPseq data in HepG2 cells demonstrated that PRPF8 binds preferentially to exons of protein-coding genes, and RNAseq analysis showed that PRPF8 silencing alters splicing events in multiple genes. Integrated and in vitro analyses revealed that PRPF8 silencing modulates fibronectin (FN1) splicing, promoting the exclusion of exon 40.2, which is paramount for binding to integrins. Consistent with this finding, PRPF8 silencing reduced FAK/AKT phosphorylation and blunted stress fiber formation. Indeed, HepG2 and Hep3B cells exhibited a lower invasive capacity in membranes treated with conditioned medium from PRPF8-silenced cells compared to medium from scramble-treated cells. This study demonstrates that PRPF8 is overexpressed and associated with aggressiveness in HCC and plays important roles in hepatocarcinogenesis by altering FN1 splicing, FAK/AKT activation and stress fiber formation.Keywords
Funding Information
- Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI17-02287, PI20/01301)
- MICINN
This publication has 40 references indexed in Scilit:
- Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinomaClinical & Experimental Metastasis, 2015
- PRPF8 defects cause missplicing in myeloid malignanciesLeukemia, 2014
- A day in the life of the spliceosomeNature Reviews Molecular Cell Biology, 2014
- FAK Inhibition Decreases Hepatoblastoma Survival Both In Vitro and In VivoTranslational Oncology, 2013
- Function of alternative splicingGene, 2013
- Transcriptional regulators in hepatocarcinogenesis – Key integrators of malignant transformationJournal of Hepatology, 2012
- Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicingHepatology, 2012
- The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cellsOncogene, 2011
- Prp8 protein: At the heart of the spliceosomeRNA, 2005
- Fibronectin at a glanceJournal of Cell Science, 2002